Research Article
Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling
Figure 1
TGM2 is upregulated in LPS-primed microglia and can be downregulated by propofol. (a) Comparison of the RNA sequencing results of control and LPS-primed BV2 cells; scatter plots showed differentially expressed genes (DEGs) related to BV2 microglia activation. (b) Venn diagram showed DEGs related to LPS-induced activation of microglia. (c) Real-time qPCR analysis of Tgm2 expression in BV2 cells upon treatment with different concentrations of LPS (). (d) Western blotting analysis of TGM2 expression in BV2 cells upon treatment with different concentrations of LPS; β-actin was loaded as a control. (e) Tgm2 expression in LPS-primed BV2 cells upon treatment with different concentrations of propofol was determined by real-time qPCR (). (f) TGM2 expression in LPS-primed BV2 cells upon treatment with different concentrations of propofol was detected by Western blotting. , , and .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |